Novavax Bilanço Sağlığı
Finansal Sağlık kriter kontrolleri 1/6
Novavax has a total shareholder equity of $-431.7M and total debt of $168.8M, which brings its debt-to-equity ratio to -39.1%. Its total assets and total liabilities are $1.8B and $2.3B respectively.
Anahtar bilgiler
-39.1%
Borç/özkaynak oranı
US$168.85m
Borç
| Faiz karşılama oranı | n/a |
| Nakit | US$1.05b |
| Eşitlik | -US$431.71m |
| Toplam yükümlülükler | US$2.25b |
| Toplam varlıklar | US$1.82b |
Son finansal sağlık güncellemeleri
Güncelleme yok
Recent updates
Finansal Durum Analizi
Kısa Vadeli Yükümlülükler: NVV1 has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.
Uzun Vadeli Yükümlülükler: NVV1 has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.
Borç-Özkaynak Tarihçesi ve Analizi
Borç Seviyesi: NVV1 has negative shareholder equity, which is a more serious situation than a high debt level.
Borcun Azaltılması: NVV1's has negative shareholder equity, so we do not need to check if its debt has reduced over time.
Bilanço
Nakit Pist Analizi
Geçmişte ortalama olarak zarar eden şirketler için, en az 1 yıllık nakit akışına sahip olup olmadıklarını değerlendiriyoruz.
İstikrarlı Nakit Pisti: NVV1 has sufficient cash runway for more than 3 years based on its current free cash flow.
Tahmini Nakit Akışı: Insufficient data to determine if NVV1 has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.